Kathleen P. Leneghan - 15 May 2021 Form 4 Insider Report for INVACARE CORP

Role: Senior VP and CFO
Signature: /s/ Kathleen P. Leneghan, by Kristofer K. Spreen, her attorney-in-fact, pursuant to Power of Attorney dated November 10, 2017, on file with the Commission
Issuer symbol: N/A
Transactions as of: 15 May 2021
Net transactions value: -$84,107
Form type: 4
Filing time: 18 May 2021, 16:47:46 UTC
Next filing: 15 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IVC	Common Shares	Tax liability	$84,107	-10,257	-6.5%	$8.20^*	146,767	15 May 2021	Direct	F1
holding	IVC	Common Shares						4,971	15 May 2021	By Invacare Retirement Savings Plan	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IVC	Employee Stock Option (Right to Buy)						22,600	15 May 2021	Common Shares	22,600		Direct	F3, F4
holding	IVC	Phantom Stock						363	15 May 2021	Common Shares	363		Direct	F3, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The surrender of these shares is for tax withholding purposes in conjunction with the vesting of restricted shares held by the reporting person.
F2	Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2020, the most recent information reasonably available.
F3	No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5.
F4	The reporting person holds previously reported options to buy 22,600 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between September 2, 2011 and March 18, 2013, at exercise prices between $13.37 to $24.45 per share, will expire between September 2, 2021 and March 18, 2023, and became exercisable between September 30, 2012 and March 31, 2017.
F5	Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan.
F6	Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2020, the most recent information reasonably available.